tiprankstipranks
Cabaletta Bio (CABA)
NASDAQ:CABA
US Market
Holding CABA?
Track your performance easily

Cabaletta Bio (CABA) Financial Statements

623 Followers

Cabaletta Bio Financial Overview

Cabaletta Bio's market cap is currently ―. The company's EPS TTM is $-2.155; its P/E ratio is -1.05; Cabaletta Bio is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.62. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -30.63M$ -27.60M$ -28.03M$ -23.15M$ -18.67M
EBITDA$ -30.20M$ -26.56M$ -27.64M$ -22.81M$ -18.31M
Net Income Common Stockholders$ -30.63M$ -27.60M$ -25.05M$ -22.27M$ -15.76M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 183.01M$ 203.22M$ 223.84M$ 241.25M$ 164.39M
Total Assets$ 204.41M$ 217.42M$ 240.46M$ 253.65M$ 173.29M
Total Debt$ 15.22M$ 7.40M$ 8.17M$ 5.02M$ 4.27M
Net Debt$ -167.79M$ -195.82M$ -215.68M$ -236.23M$ -160.12M
Total Liabilities$ 30.17M$ 17.90M$ 18.74M$ 17.45M$ 12.36M
Stockholders Equity$ 174.24M$ 199.52M$ 221.72M$ 236.20M$ 160.92M
Cash Flow-
Free Cash Flow$ -20.58M$ -21.56M$ -24.80M$ -16.63M$ -12.67M
Operating Cash Flow$ -20.32M$ -20.79M$ -23.99M$ -16.45M$ -12.60M
Investing Cash Flow$ 12.25M$ 23.73M$ -812.00K$ 1.14M$ -65.00K
Financing Cash Flow$ 71.00K$ 379.00K$ 6.86M$ 93.05M$ 98.00K
Currency in USD

Cabaletta Bio Earnings and Revenue History

Cabaletta Bio Debt to Assets

Cabaletta Bio Cash Flow

Cabaletta Bio Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis